Source : ITPC GLOBAL Today, Monday, 24 July 2017, during the 9th International AIDS Conference on HIV Science in Paris (IAS 2017), HIV treatment activists from around the world collectively blocked access to
Beirut, Lebanon, 12–14 July 2017 By the end of 2015, the estimated number of people living with HIV in the Region had reached 330 000. With a continuously growing epidemic coupled with low
WHO urges action against HIV drug resistance threat 20 JULY 2017 | GENEVA – WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys
Source : By Frederick M The Supreme Court of the United States on May 30, 2017 adopted a rule of international exhaustion of patent rights for the United States in Impression Products v.
MENA Regional Civil Society Capacity Building and Dialogue Meeting CRG Strategic Initiative; MENA Regional Coordination and Communication Platform ITPC-MENA In line with the Global Fund 2017-2022 Strategy approved by the Global Fund Board
By: Ellen ‘t Hoen, Global Health Unit Department of Health Sciences, UMCG Groningen, e.f.m.t.hoen@umcg.nl On 30 January the World Trade Organization (WTO) announced the first ever amendment to the TRIPS Agreement under the headline
Source : hepCoalition The HepC Pill Bill-An insight into the availability, pricing and accessibility of HCV treatment Introduction to Direct Acting Antivirals Hepatitis C treatment has remarkably evolved over the years. The previously
Source : M-Colaition This resource guide is designed to assist civil society organizations in understanding how to access funding from the Global Fund (GF) and effectively engage in country dialogue through all the
Know your timeline! Submission dates for MENA Global Fund Funding Requests : Greetings from the Regional Communication and Coordination Platform for Middle East & North Africa, hosted by ITPC-MENA. We are preparing a
by Catherine Saez, Intellectual Property Watch: The United Nations Human Rights Council held a panel discussion yesterday to exchange views on good practices and key challenges relevant to access to medicines. The panel
